Medtronic: Karen Parkhill on Empowering Women, Business Transformation

In her six years as chief financial officer at Medtronic, Karen Parkhill has helped advance women's representation at all levels of the company

She's proud of the progress. As of 2022, women make up 51% of Medtronic employees, 43% of managers and above, and 36% of its board of directors.

But for Parkhill, that's still not enough.

"The medical device industry has many great women in senior levels, but we need more," she said in a recent episode of the MedtronicTalks podcast. "Where women lead, the world is better off."

For Parkhill, those words are at the heart of her personal focus on mentoring and developing a rising number of women executives. Her commitment to inclusion, diversity, and equity led her to support the company's international pay equity efforts and Medtronic has achieved 100% gender and ethnically diverse pay equity in the aggregate in the U.S. and 99% globally. She also serves as the Executive Sponsor of the Medtronic Women's Network's hub for women vice presidents as well as Executive Sponsor of the Medtronic PRIDE Network for LGBTQ+ employees and allies.

Parkhill began her career at JP Morgan in investment banking and rose to CFO of its commercial banking business. She went on to become vice chairman and CFO at Comerica, before stepping into the healthcare technology industry as CFO at Medtronic, where she's helped to drive transformation across both the finance function and the company.

"It wasn't daunting to me to learn a new industry, but it was my next, new challenge," said Parkhill, adding that the company's higher purpose to help patients provided the real appeal of joining Medtronic. "What we do to alleviate pain, restore health, and extend lives really does change lives."

Hear more from Karen Parkhill about her observations of the MedTech industry, the progress Medtronic has made, and what she expects from the future in this episode of the MedtronicTalks Podcast. And learn more about the company's efforts to remove barriers and shape equitable outcomes in the Global Inclusion, Diversity & Equity 2022 Annual Report.

Medtronic, Monday, March 27, 2023, Press release picture

View additional multimedia and more ESG storytelling from Medtronic on 3blmedia.com.

Contact Info:
Spokesperson: Medtronic
Website: https://www.3blmedia.com/profiles/medtronic
Email: info@3blmedia.com

SOURCE: Medtronic



View source version on accesswire.com:
https://www.accesswire.com/745933/Medtronic-Karen-Parkhill-on-Empowering-Women-Business-Transformation

News Provided by ACCESSWIRE via QuoteMedia

MDT
The Conversation (0)

PrairieSky Announces First Quarter 2024 Results, Record Oil Royalty Production

-

PrairieSky Royalty Ltd. ("PrairieSky" or the "Company") (TSX: PSK) is pleased to announce its first quarter ("Q1 2024") operating and financial results for the three-month period ended March 31, 2024.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

PrairieSky Announces Fourth Quarter And Year-End Results For 2023, Including Record Oil Royalty Production, Strong Leasing Activity And Increased Annual Dividend

PrairieSky Royalty Ltd. (" PrairieSky " or the " Company ") (TSX: PSK) is pleased to announce its fourth quarter (" Q4 2023 ") and year-end operating and financial results for the period ended December 31, 2023. PrairieSky is also pleased to announce a 4% increase in its annual dividend to $1.00 per common share ($0.25 per common share quarterly).

Fourth Quarter Highlights

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

PrairieSky Announces 2023 Third Quarter Results

PrairieSky Royalty Ltd. (" PrairieSky " or the " Company ") (TSX: PSK) is pleased to announce its third quarter (" Q3 2023 ") results for the three-month period ended September 30, 2023.

Third Quarter Highlights

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
doctor with hands together, palms up below digital medical symbols

Innovations and Opportunities in European Healthcare Technologies

In recent years, European companies have emerged as trailblazers in healthcare technology, effectively changing the face of health and patient care. Through innovation, they're not only improving systems, processes and patient outcomes but also saving lives.

These advanced European technologies are often only distributed and implemented exclusively within the European Union. The good news is that it doesn't need to stay this way.

Bringing European healthcare technologies to the North American market can potentially improve healthcare in this part of the world, open up new market opportunities for investors and expose those companies to significant growth capital.

Keep reading...Show less
Illustration of heart attack.

Investing in Cardiovascular MedTech Companies

Cardiovascular diseases remain the leading global cause of death, taking an estimated 17.9 million lives annually, based on data from the World Health Organisation. Over 80 percent of these deaths are due to heart attacks and strokes, while one-third of them occur in people under seventy years of age.

Efforts to address the core risk factors associated with cardiovascular diseases are coinciding with recent innovations in medical technology, which have been critical in not only preventing and managing them but also increasing the survival rate.

As medical technologies associated with the diagnosis and treatment of cardiovascular disease continue to evolve, medical technology companies provide an opportunity for investors to create wealth through health.

Keep reading...Show less

Thermo Fisher Scientific Reports First Quarter 2024 Results

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the first quarter ended March 30, 2024.

First Quarter 2024 Highlights

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
March Quarterly Appendix 4C

March Quarterly Appendix 4C

Cardiex Limited (ASX:CDX) (Cardiex, the Company) has released its Quarterly Cash Flow Report.


Keep reading...Show less
Cardiex March 2024 Quarter Update

Cardiex March 2024 Quarter Update

Cardiex Limited (ASX:CDX) (Cardiex, the Company) is pleased to present its Quarterly Report.
Keep reading...Show less

Medtronic: Americans Favor Quality Over Quantity in Pursuit of Longevity

According to a new survey from Medtronic and Morning Consult, nearly two-thirds of U.S. adults say they'd opt for a shorter, healthier life than a longer one with health issues

Americans overwhelmingly say that when they think about longevity, it's more than just living longer - it's about living their healthiest, best lives. While most want to live to 90-well past the average U.S. life expectancy of 77.5 years-nearly two-thirds (66%) would choose a shorter, healthier life over a longer one with health issues. These findings, from a survey conducted by global healthcare technology leader Medtronic with Morning Consult, highlight a gap between U.S. adults' desire to live healthier years and the opportunity for more people to improve their quality of life through healthcare technology

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×